TRYPANOSOMA CRUZI - ANVISA Registration 81816720082

Access comprehensive regulatory information for TRYPANOSOMA CRUZI in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81816720082 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until Feb 17, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, WIENER LABORATORIOS S.A.I.C., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81816720082
2 Related Devices
Registration Details
ANVISA Registration Number: 81816720082
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

CHAGAS TESA VIRCLIA® IgG+IgM MONOTEST
Risk Class IV

Registration Details

81816720082

25351637723202312

31167508000102

Company Information

Dates and Status

Feb 17, 2025

17/02/2035

09/18/2025 19:00:01

CHAGAS TESA VIRCLIA® IgG+IgM MONOTEST
Risk Class IV

Registration Details

81816720082

25351637723202312

31167508000102

Dates and Status

Feb 17, 2025

17/02/2035

09/18/2025 19:00:01